Harness Therapeutics
PrivateLast Round
Grant
Jun 9, 2026
Total Funding Raised
$18.69M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Harness Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Grant round in June 2026.
Harness Therapeutics is a biotechnology company developing next-generation therapeutics to transform the treatment of neurodegenerative diseases through precision protein upregulation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Harness Therapeutics Comparables
Compare Harness Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vico Therapeutics | 83% | |
| Atalanta Therapeutics | 78% | |
| Cloverleaf Bio | 75% |
For institutional investors. Book with your work email.
Harness Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 9, 2026 | ||||
| VC Round | Jan 27, 2025 | ||||
| VC Round | Nov 28, 2023 | ||||
| Seed | May 31, 2022 | ||||
| Seed | Jun 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Harness Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | VC Round, Seed |
| Epidarex Capital | VC Round, Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Ono Venture Investment, Inc. | VC Round |
| OVI Partners | VC Round |
| Takeda Ventures | VC Round, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 9, 2026
Received grant from The Michael J. Fox Foundation.
- Oct 7, 2025
Partnered with Ono Venture Investment for research.
For institutional investors. Book with your work email.
Harness Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Harness Therapeutics's valuation, stock price, and market status.
Is Harness Therapeutics a public or private company?
Harness Therapeutics is a private company.
What is the current stock price of Harness Therapeutics?
Harness Therapeutics is a private company, so its shares have no public market price. Caplight tracks Harness Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Harness Therapeutics worth (valuation)?
Valuation information for Harness Therapeutics is not publicly available.
Can I buy Harness Therapeutics stock?
Harness Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Harness Therapeutics's last funding round?
Harness Therapeutics's most recent funding round was Grant on June 9, 2026.
Who are the main investors in Harness Therapeutics?
Key investors in Harness Therapeutics include SV Health Investors, Epidarex Capital, Ono Venture Investment, Inc., Takeda Ventures.
Will Harness Therapeutics IPO soon?
No public IPO plans have been announced for Harness Therapeutics.
How can I track Harness Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Harness Therapeutics's shares on secondary markets.